Watanabe Todd Franklin

EDGAR CIK 0001801061

Arcutis Biotherapeutics, Inc. - ARQT

  1. Manufacturing
  2. Chemicals
  3. Pharmaceutical Preparations
CEO Director
Reporting Person's title: President and Chief Exec
Direct Buys
2
$21,250
6,038 Shares
Direct Sells
5
($563,408)
-59,509 Shares
Indirect Buys
0
$0
0 Shares
Indirect Sells
0
$0
0 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
11/30/2024
12/03/2024
Buy
2,038 @ $7.11
 $14,482 838,430 (0.24%) Direct
11/04/2024
11/05/2024
Sell
-13,871 @ $8.68
 ($120,459) 832,392 (-1.64%) Direct
08/02/2024
10b5-1
08/05/2024
Sell
-14,487 @ $9.02
 ($130,648) 846,263 (-1.68%) Direct
05/31/2024
12/03/2024
Buy
4,000 @ $1.69
 $6,768 836,392 (0.48%) Direct
05/02/2024
10b5-1
05/03/2024
Sell
-13,783 @ $8.74
 ($120,433) 860,750 (-1.58%) Direct
03/04/2024
10b5-1
03/06/2024
Sell
-14,903 @ $11.12
 ($165,739) 874,533 (-1.68%) Direct
02/28/2024
10b5-1
03/01/2024
Sell
-2,465 @ $10.60
 ($26,129) 889,436 (-0.28%) Direct